High Implementation Adherence to Lenalidomide in Multiple Myeloma
this novel assessment of LEN adherence in MM patients demonstrated high implementation adherence and cycle duration compliance.
Authors
- Hila Magen (ORCID: https://orcid.org/0000-0002-3990-394X)
- Avi Leader (ORCID: https://orcid.org/0000-0003-2245-345X)
- Iuliana Vaxman (ORCID: https://orcid.org/0000-0002-8390-064X)
- Arnon Nagler (ORCID: https://orcid.org/0000-0002-0763-1265)
- Eric Tousset (ORCID: https://orcid.org/0000-0001-8798-8127)
- Antoine Pironet (ORCID: https://orcid.org/0000-0002-1610-3050)
- Irina Amitai (ORCID: https://orcid.org/0000-0003-3387-5930)
- Alon Rozental (ORCID: https://orcid.org/0000-0001-7339-5494)
- Sabina De Geest (ORCID: https://orcid.org/0000-0001-6596-7237)
- Pia Raanani (ORCID: https://orcid.org/0000-0001-9973-639X)
Institutions
- Memorial Sloan Kettering Cancer Center (US)
- Tel Aviv University (IL)
- University of Basel (CH)
- Sheba Medical Center (IL)
- Rabin Medical Center (IL)
- Department of Biomedicine Basel (CH)
- NXP (Belgium) (BE)
- Department of Public Health (MM)
Publication Details
- Journal
- Cancers
- Published
- 2025-11-06
- DOI
- https://doi.org/10.3390/cancers17213587
- Primary Topic
- Multiple Myeloma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00